대한신장학회

Skip Navigation: Skip to contents

KOR
ENG
전체메뉴보기

간행물 검색

현재 페이지 경로

HOME
간행물
간행물 검색

논문분류	춘계학술대회 초록집
제목	Statin therapy is more effective in early stage of chronic kidney disease patients
저자	Eun Yeong Cho* 1, Chana Myoung1, Hong-Suk Park1, Ae Jin Kim1, Han Ro1, Jae Hyun Chang1, Hyun Hee Lee1, Wookyung Chung1, Ji Yong Jung1
출판정보	2016; 2016(1):
키워드	Chronic Kidney Disease, Outcomes, Statin
초록	Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascular disease (CVD). Statin treatment is known as one of options to reduce the risk of CVD. However, it is still uncertain if statin treatment affects the renal progression and outcomes in CKD patients. The aim of this study was to determine the effect of statin treatment in CKD patients on clinical outcomes. Methods: We retrospectively reviewed CKD patients who visited to Gachon University Gil Medical Center with renal problems from 2003 to 2013. From a total 14497 CKD patients, 858 statin users were paired with 1:1 with non-users for analysis using propensity sore matching. The primary outcome was renal progression including doubling of serum creatinine and renal death. Secondary outcome was the all-cause mortality. We also analyzed the data from stratification to find out the interactive factors for composite outcomes (creatinine doubling, renal death and all-cause mortality). Results: Statin was prescribed for 13.5% of study subjects. Statin treatment associated hazard ratios (HRs) [95% confidence intervals (CIs)] for the doubling of serum creatinine levels was significant only in patients with eGFR (estimated glomerular filtration rate) ≥ 30 ml/min/1.73m2 were 0.744 (0.635 – 0.873) in the unmatched cohort and 0.767 (0.596 – 0.986) in the matched cohort. In analyses for secondary outcomes, HRs (95% CIs) for all-cause mortality were 0.655 (0.502 – 0.855) in the unmatched cohort and 0.537 (0.297 – 0.973) in the matched cohort. The HRs (95% CIs) for composite outcomes among those with and without eGFR ≥ 30 ml/min/1.73m2 were 0.764 (0.613 – 0.952) and 1.232 (0.894 – 1.697), respectively (P for interaction, 0.017). Conclusion: These results suggest that statin treatment in early stages of CKD patients may useful related to renal progression and all-cause mortality. Further evaluation is needed to find out if early administration of statins in CKD patients improves the outcomes.
원문(PDF)	PDF 원문보기

목록

위로가기